Difference between revisions of "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265) (Q8388)"
Jump to navigation
Jump to search
(Removed claim: PubMed ID (P140): 32172669) |
(Changed [en] description: Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585.) |
||||||||||||||
| (58 intermediate revisions by the same user not shown) | |||||||||||||||
| description / en | description / en | ||||||||||||||
| - | + | Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585. | |||||||||||||
| Property / License | |||||||||||||||
| - | |||||||||||||||
| Property / License: cc-by / rank | |||||||||||||||
| - | |||||||||||||||
| Property / License: cc-by / reference | |||||||||||||||
| - | |||||||||||||||
| Property / title | |||||||||||||||
| + | Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (English) | ||||||||||||||
| Property / title: Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title: Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (English) / reference | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1080/22221751.2020.1735265 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier: 10.1080/22221751.2020.1735265 / reference | |||||||||||||||
| + | |||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Emerg Microbes Infect | ||||||||||||||
| Property / Published In Name String: Emerg Microbes Infect / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String: Emerg Microbes Infect / reference | |||||||||||||||
| + | |||||||||||||||
| Property / PMC Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / PMC Identifier: PMC7103730 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PMC Identifier: PMC7103730 / reference | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 32172669 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID: 32172669 / reference | |||||||||||||||
| + | |||||||||||||||
| Property / License | |||||||||||||||
| + | cc-by | ||||||||||||||
| Property / License: cc-by / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / License: cc-by / reference | |||||||||||||||
| + | |||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 14 March 2020
| ||||||||||||||
| Property / Publication Date: 14 March 2020 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date: 14 March 2020 / reference | |||||||||||||||
| + | |||||||||||||||
| Property / Microsoft Academic ID | |||||||||||||||
| + | |||||||||||||||
| Property / Microsoft Academic ID: No data / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Microsoft Academic ID: No data / reference | |||||||||||||||
| + | |||||||||||||||
| Property / COVIDWHO ID | |||||||||||||||
| + | |||||||||||||||
| Property / COVIDWHO ID: 8788 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / COVIDWHO ID: 8788 / reference | |||||||||||||||
| + | |||||||||||||||
| Property / CORD-19 Internal Unique Identifier | |||||||||||||||
| + | 6wdwrttn | ||||||||||||||
| Property / CORD-19 Internal Unique Identifier: 6wdwrttn / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / CORD-19 Internal Unique Identifier: 6wdwrttn / reference | |||||||||||||||
| + | |||||||||||||||
| Property / sha1 Hash for Publication | |||||||||||||||
| + | 51b99ff77b798aa00a8a10ecb4f62312a3f562d2 | ||||||||||||||
| Property / sha1 Hash for Publication: 51b99ff77b798aa00a8a10ecb4f62312a3f562d2 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / sha1 Hash for Publication: 51b99ff77b798aa00a8a10ecb4f62312a3f562d2 / reference | |||||||||||||||
| + | |||||||||||||||
| Property / CORD-19 Article Source String | |||||||||||||||
| + | PMC | ||||||||||||||
| Property / CORD-19 Article Source String: PMC / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / CORD-19 Article Source String: PMC / reference | |||||||||||||||
| + | |||||||||||||||
| Property / Volume | |||||||||||||||
| + | TRUE | ||||||||||||||
| Property / Volume: TRUE / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume: TRUE / reference | |||||||||||||||
| + | |||||||||||||||
| Property / Issue | |||||||||||||||
| + | TRUE | ||||||||||||||
| Property / Issue: TRUE / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Issue: TRUE / reference | |||||||||||||||
| + | |||||||||||||||
| Property / CORD-19 Full Text File | |||||||||||||||
| + | comm_use_subset | ||||||||||||||
| Property / CORD-19 Full Text File: comm_use_subset / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / CORD-19 Full Text File: comm_use_subset / reference | |||||||||||||||
| + | |||||||||||||||
| Property / Collection or Dataset of Origin | |||||||||||||||
| + | |||||||||||||||
| Property / Collection or Dataset of Origin: COVID-19 Open Research Dataset (CORD-19). 2020. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / has part | |||||||||||||||
| + | |||||||||||||||
| Property / has part: Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 11:56, 17 May 2020
Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265)
|
Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585.
|
Statements
Coronavirus disease 2019
0 references
SARS-CoV-2
0 references
pneumonia
0 references
diagnosis
0 references
treatment
0 references
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (English)
51b99ff77b798aa00a8a10ecb4f62312a3f562d2
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
